Skip to main content
IMA
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
0
Price
$5.75
Mkt Cap
$66.327M
52W Low
$3.94
52W High
$216
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, IMA was trading at $5.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $66.3M. The 52-week trading range was $3.94 to $216.00.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed IMA - Latest Insights

IMA
Apr 30, 2026, 4:32 PM EDT
Filing Type: DEFA14A
Importance Score:
7
ImageneBio Seeks Shareholder Approval for 7.6% Expansion of Equity Incentive Plan
Sentiment: Neutral
View Wiseek Article
IMA
Apr 21, 2026, 4:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Omega Fund, including Director Stampacchia, invests $2.5M in ImageneBio PIPE
Sentiment: Positive
View Wiseek Article
IMA
Apr 16, 2026, 7:23 PM EDT
Filing Type: 4
Importance Score:
9
OrbiMed Advisors, a Director, Invests $3.75M in ImageneBio Private Placement
Sentiment: Positive
View Wiseek Article
IMA
Apr 13, 2026, 8:21 AM EDT
Filing Type: 424B3
Importance Score:
8
ImageneBio Registers 2.5M Common Shares for Resale by Investors from Recent $30M Private Placement
Sentiment: Negative
View Wiseek Article
IMA
Apr 13, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
8
ImageneBio Secures $30M in Private Placement of Pre-Funded Warrants for Clinical Development
Sentiment: Neutral
View Wiseek Article
IMA
Apr 13, 2026, 7:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
ImageneBio Secures $30M Private Placement, Bolstering Funds for Clinical Programs
Sentiment: Neutral
View Wiseek Article
IMA
Mar 10, 2026, 8:33 AM EDT
Filing Type: 10-K
Importance Score:
9
ImageneBio Reports Positive Clinical Data for Lead Asset IMG-007, Secures $75M PIPE Financing, and Notes Competitor Exit
Sentiment: Positive
View Wiseek Article
IMA
Mar 10, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
9
ImageneBio Secures Substantial Cash Runway of $135.3M, Reports Improved Full-Year EPS
Sentiment: Positive
View Wiseek Article
IMA
Mar 10, 2026, 8:06 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
ImageneBio Cuts 2025 Loss Per Share by Over 50% to $9.64
Sentiment: Positive
View Wiseek Article